Results 61 to 70 of about 12,533 (181)

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers

open access: yesPharmaceuticals, 2023
The feasibility of using lipid–polymer hybrid (LPH) nanocarriers as a potential platform for the intranasal delivery of ziprasidone (ZP), a second-generation antipsychotic, was explored.
Hadel A. Abo El-Enin   +6 more
doaj   +1 more source

Antipsychotic‐Induced Hyperprolactinemia [PDF]

open access: yes, 2009
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90238/1/phco.29.1.64 ...
Bostwick, Jolene R.   +2 more
core   +1 more source

Ensuring generalizability and clinical utility in mental health care applications: Robust artificial intelligence‐based treatment predictions in diverse psychosis populations

open access: yesPsychiatry and Clinical Neurosciences, Volume 80, Issue 1, Page 64-75, January 2026.
Aim Artificial Intelligence (AI)‐based prediction models of treatment response promise to revolutionize psychiatric care by enabling personalized treatment, but very few have been thoroughly tested in different samples or compared to current clinical standards.
Fiona Coutts   +10 more
wiley   +1 more source

Ziprasidone in the treatment of mania in bipolar disorder

open access: yesNeuropsychiatric Disease and Treatment, 2007
Stephen E Nicolson1, Charles B Nemeroff21From the Department of Psychiatry, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA; 2From the Department of Psychiatry and Behavioral Sciences, Emory University, School of Medicine ...
Stephen E Nicolson, Charles B Nemeroff
doaj  

Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE data [PDF]

open access: yes, 2012
Introduction: Antipsychotic drugs exert antipsychotic effects by blocking dopamine D2 receptors in the treatment of schizophrenia. However, effects of D2 receptor blockade on neurocognitive function still remain to be elucidated.
Agid   +63 more
core   +1 more source

A Case of Pegfilgrastim‐Induced Sweet Syndrome and Literature Review of Similar Cases

open access: yesCase Reports in Oncological Medicine, Volume 2026, Issue 1, 2026.
Sweet′s syndrome (SS), also known as acute febrile neutrophilic dermatosis, is a rare disorder characterized by painful erythematous lesions, fever, and neutrophilic dermal infiltrates. Drug‐induced Sweet′s syndrome (DISS) is most often associated with short‐acting granulocyte colony‐stimulating factors (G‐CSF), whereas pegfilgrastim, the long‐acting ...
Meghana Kesireddy   +4 more
wiley   +1 more source

Psychovegetative syndrome: challenges in diagnosis and effective treatment

open access: yesМедицинский совет, 2019
Autonomic dysfunction syndrome (ADS) includes the somatic (autonomic) function disorders of various origin and manifestations caused by their neurogenic regulation disorder.
О. V. Kotova   +2 more
doaj   +1 more source

The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. [PDF]

open access: yes, 2020
In comparison to batteries of standard neuropsychological tests, cognitive neuroscience tests may offer a more specific assessment of discrete neurobiological processes that may be aberrant in schizophrenia.
Ball, M Patricia   +21 more
core  

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course

open access: yesActa Biomedica Scientifica, 2019
Background. The use of atypical antipsychotics in schizophrenia contributes to the reduction of psychotic, affective, negative and cognitive disorders.Aims.
L. A. Ivanova   +4 more
doaj   +1 more source

Tranquilização rápida para pacientes agitados nos serviços de emergência psiquiátrica: um ensaio clínico randomisado de olanzapina, ziprasidona, haloperidol mais prometazina, haloperidol mais midazolam e haloperidol em monoterapia [PDF]

open access: yes, 2011
OBJECTIVE: To compare the effectiveness of intramuscular olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone as the first medication(s) used to treat patients with agitation and aggressive behavior ...
Baldaçara, Leonardo   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy